Education
About Us
Working with TipRanks
Follow Us
Adynxx, Inc. (ADYX)
OTHER OTC:ADYX
ADYX Stock Chart & Stats
$0.02
$0.00(0.00%)
At close: 4:00 PM EST
$0.02
$0.00(0.00%)
Day’s Range― - ―
52-Week Range― - ―
Previous CloseN/A
Volume44.00
Average Volume (3M)N/A
Market Cap
$581.00
Enterprise ValueN/A
Total Cash (Recent Filing)$331.00K
Total Debt (Recent Filing)$9.48M
Price to Earnings (P/E)―
Beta-152.64
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding5,808,000
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.00
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ADYX FAQ
What was Adynxx, Inc.’s price range in the past 12 months?
Currently, no data Available
What is Adynxx, Inc.’s market cap?
Adynxx, Inc.’s market cap is $581.00.
When is Adynxx, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Adynxx, Inc.’s earnings last quarter?
Currently, no data Available
Is Adynxx, Inc. overvalued?
According to Wall Street analysts Adynxx, Inc.’s price is currently Overvalued.
Does Adynxx, Inc. pay dividends?
Adynxx, Inc. pays a Monthly dividend of $6.3 which represents an annual dividend yield of N/A. See more information on Adynxx, Inc. dividends here
What is Adynxx, Inc.’s EPS estimate?
Adynxx, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Adynxx, Inc. have?
Adynxx, Inc. has 5,808,000 shares outstanding.
What happened to Adynxx, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Adynxx, Inc.?
Currently, no hedge funds are holding shares in ADYX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Adynxx, Inc.
Adynxx, Inc., a clinical stage biopharmaceutical company, focuses on the development and marketing of transcription factor decoy technologies for the treatment of pain and inflammatory diseases. It is involved in the development of AYX platform of transcription factor decoys, including brivoligide, which is in Phase II clinical development for the reduction of postoperative pain; and AYX2, a pre-clinical candidate intended for the treatment of focal chronic pain. The company was founded in 2007 and is headquartered in San Francisco, California.
Technical Analysis
Salarius Pharmaceuticals
―
PharmaCyte Biotech
―
Enveric Biosciences
―
PainReform
―
GRI Bio
―